Abstract
Among the other symptoms, impaired olfactory function such as odor identification, threshold, and discrimination have been reported in patients with fibromyalgia syndrome (FMS). To investigate olfactory bulb (OB) volumes in FMS, by using magnetic resonance imaging (MRI), and to make reasonable suggestions are the goals of the present study. The study included 62 individuals as the FMS group (n = 30) and the control group (n = 32). MRI examinations were performed by a 1.5-T scanner and a standard head coil was used for the images. The coronal T2-weighted images were used for to measure OB volumes. Right, left, and total OB volumes were calculated with the aid of these images. The mean age of the FMS group was 44.2 ± 8.3 years and the control group was 41.7 ± 3.53 years. The mean volume of the right OB was 74.9 ± 12.4 mm3 in the FMS group and was 92.6 ± 12.9 mm3 in the control group. The mean value of the left OB volume was 74.3 ± 10.8 mm3 in the FMS group and 92.8 ± 12.6 mm3 in the control group. The mean of the total OB volume was 146.6 ± 20.81 mm3 in the FMS group and 186.5 ± 23.5 mm3 in the control group. Left, right, and total OB volumes were significantly lower in the FMS group than in the control group (all p < 0.05). Female patients with FMS are under the risk of the decreased olfactory bulb volumes. This situation should be kept in mind for proper and reasonable management of this tough syndrome.
Similar content being viewed by others
References
Williams DA, Clauw DJ (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10:777–791
Koklu K, Sarıgul M, Ozisler Z, Sirzai H, Ozel S (2016) Handgrip strength in fibromyalgia. Arch Rheumatol 31:158–161
Branco JC et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453
Yazmalar L et al (2016) High frequency of fibromyalgia in patients with acne vulgaris. Arch Rheumatol 31:170–175
Buschhüter D et al (2008) Correlation between olfactory bulb volume and olfactory function. NeuroImage 42:498–502
Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46:527–552
Moberg PJ et al (2013) Meta-analysis of olfactory function in schizophrenia, first degree family members, and youths at-risk for psychosis. Schizophr Bull 40:50–59
Ortega-Hernandez OD, Kivity S, Shoenfeld Y (2009) Olfaction, psychiatricdisorders and autoimmunity: is there a common geneticassociation. Autoimmunity 42:80–88
Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163:155–167
Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60
Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS One 7:e45544
Shoenfeld Y (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28:165–169
Rombaux P, Duprez T, Hummel T (2009) Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology 47:3–9
Mueller A et al (2005) Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm 112:1363–1370
Wilbarger JL, Cook DB (2011) Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Arch Phys Med Rehabil 92:653–656
Jörn L, Hans-Georg K, Jörg W, Thomas H (2012) Self-ratings of higher olfactory acuity contrast with reduced olfactory test results offibromyalgia patients. Int J Psychophysiol 86:182–186
Howard A, Nancy AL (2014) Olfactory impairment in patients with thefibromyalgia syndrome and systemic sclerosis. Immunol Res 60:201–207
Burgmer M et al (2012) Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16:636–647
Staud R (2011) Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol 29:109–117
Schweinhardt P, Sauro KM, Bushnell MC (2008) Fibromyalgia: a disorder of the brain. Neuroscientist 14:415–421
Lutz J et al (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58:3960–3969
Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain. J Neurosci 27:4004–4007
Burgmer M et al (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71(5):566–573
Martines-Marcos A (2009) On the organization of olfactory and vomeronasal cortices. Prog Neurobiol 87(1):21–30
Arnold LM et al (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67(8):1219–1225
Sayılır S (2016) The relationship between symptom severity and cognitive functions of fibromyalgia syndrome with obesity. Turk J Osteoporos 22:129–131
Negoias S et al (2010) Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 169(1):415–421
Drevets WC (1999) Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 877:614–637
Drevets WC, Bogers W, Raichle ME (2002) Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12:527–544
Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, Schlosser RG (2008) Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 33:199–208
Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647
Taylor AG et al (2015) Stress, Inflammation and Pain: A Potential Role for Monocytes in Fibromyalgia-related Symptom Severity. Stress Health. doi:10.1002/smi.2648
Bazzichi L et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230
Selda B et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25(3):188–190
Jill MR, Sarantopoulos CD (2009) Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy. Med Hypotheses 73:177–183
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Funding
None.
Rights and permissions
About this article
Cite this article
Sayılır, S., Çullu, N. Decreased olfactory bulb volumes in patients with fibromyalgia syndrome. Clin Rheumatol 36, 2821–2824 (2017). https://doi.org/10.1007/s10067-017-3772-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3772-9